Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102202742 | 10220274 | 2 | F | 20131016 | 20150925 | 20140606 | 20150930 | EXP | BR-ROCHE-1410865 | ROCHE | 71.79 | YR | F | Y | 47.90000 | KG | 20150930 | N | PH | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102202742 | 10220274 | 1 | PS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | N | N3583,H4263 | 103792 | |||||||||
| 102202742 | 10220274 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | ADMINISTRATION OF 209 ML OF TRASTUZUMAB (FIFTH CYCLE) | N | N3583,H4263 | 103792 | 383.2 | MG | ||||||
| 102202742 | 10220274 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | CYCLE 10 | N | N3583,H4263 | 103792 | 388 | MG | ||||||
| 102202742 | 10220274 | 4 | C | ATENOLOL. | ATENOLOL | 1 | Oral | D | 0 | ||||||||||
| 102202742 | 10220274 | 5 | C | ENALAPRIL | ENALAPRIL | 1 | Oral | D | 0 | ||||||||||
| 102202742 | 10220274 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | D | 0 | ||||||||||
| 102202742 | 10220274 | 7 | C | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | D | 0 | ||||||||||
| 102202742 | 10220274 | 8 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | D | 0 | ||||||||||
| 102202742 | 10220274 | 9 | C | DOCETAXEL. | DOCETAXEL | 1 | Unknown | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102202742 | 10220274 | 1 | Breast cancer |
| 102202742 | 10220274 | 4 | Hypertension |
| 102202742 | 10220274 | 5 | Hypertension |
| 102202742 | 10220274 | 6 | Hypertension |
| 102202742 | 10220274 | 7 | Breast cancer |
| 102202742 | 10220274 | 8 | Breast cancer |
| 102202742 | 10220274 | 9 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102202742 | 10220274 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102202742 | 10220274 | Chills | |
| 102202742 | 10220274 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102202742 | 10220274 | 1 | 201301 | 201304 | 0 | |
| 102202742 | 10220274 | 2 | 20131016 | 20131016 | 0 | |
| 102202742 | 10220274 | 3 | 20140326 | 20140326 | 0 | |
| 102202742 | 10220274 | 7 | 201210 | 201301 | 0 | |
| 102202742 | 10220274 | 8 | 201210 | 201301 | 0 | |
| 102202742 | 10220274 | 9 | 201301 | 201304 | 0 |